Last reviewed · How we verify

NCT07329465

Comparative Effects of Tabata Training and Periodized Resistance Training in Sprinters

Completed NA Last updated 9 January 2026
What this trial tests

NA trial testing Periodized Resistance Training in Sports Physical Therapy in 38 participants. Completed in 5 November 2025.

Timeline
21 November 2024
Primary endpoint
5 October 2025
5 November 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment38
Start date21 November 2024
Primary completion5 October 2025
Estimated completion5 November 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 35, any sex, with Sports Physical Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a parallel group randomized control trail that utilized purposive sampling to recruit 32 participants. The 32 students are divided into 2 groups, namely the group of Tabata Training and Periodized Resistance Training. Periodized resistance training exercises will be performed three days a week during the eight-week period in group A. The periodized resistance training program started with warm up and continued by some exercises such as smith press, seated press, squat, lying dumbbell leg cruel, leg press, lying burble extension, sit up and finally the subjects cooled down. At the beginning of the study, the exercises will be conducted 60% intensity while eight maximum repetition and 10% intensity will be added after every week. The cycle will be repeated 1 times each exercise for a total of 8 repetitions. Each exercise will performed individually by each participant in a group activity. Tabata training will be performed in group B that included their Exercise sessions started with a general warm-up, and then stretching session followed by a specific warmup. The general warm-up consisted of 5 minutes of marching in place at 60% of the estimated maximal heart rate (HR max= 220 - age) measured with a heart rate monitor. The stretching session included major muscle groups and joints including triceps, deltoid, trapezius, neck extensors, pectoralis, biceps, latissimus dorsi, hamstrings, quadriceps, and gastrocnemius. Each stretch will maintained for 15 to 20 seconds. Then, a specific warm-up session followed that included 2 thruster repetitions of 30 seconds each, followed by 30 seconds of rest. Thrusters are a combination of 2 strength-training exercises: squat and overhead press. After the specific warm-up will be completed, the Tabata protocol began with participants performing thrusters as fast as possible for 20 seconds, followed by 10 seconds of resting. During the active part, participants will encouraged to reach near 100% of their HR max. Intensity will evaluated with heart rate monitors and also with the Borg rating of perceived exertion. The cycle will be repeated 7 times for a total of 8 repetitions in 4 minutes. After completing the protocol, a 5-minute cool-down period (slow walking and stretching exercises) was completed. Total duration of the Tab protocol will be approximately 19 to 20 minutes and will be completed 3 times per week for 8 consecutive weeks

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Periodized Resistance Training

Trials testing the same drug.

Other recruiting trials for Sports Physical Therapy

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07329465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing